Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
fda
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
cancer
cancer immunotherapy
chronic kidney disease
clinical trials
europe blog main
europe top stories
investing
medicare
messenger rna
novartis
What
ipo
4
×
new
4
×
bio
companies
life
million
momentum
raised
roundup
science
therapeutics
week
activity
allogene
approvals
arrival
biogen
biotech
biotechs
cancer
clamped
club
continued
covid
crispr
crop
days
delays
developing
diversity
economic
exceeded
fast
fda
firms
group
hasn’t
haul
hot
immunotherapy
Language
unset
Current search:
ipo
×
new
×
national
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M